BLMN vs HZO

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score raises concerns about bankruptcy risk assessment. Despite a high dividend yield of 7.83%, the unsustainable payout ratio of 186.49% and negative profitability metrics signal severe earnings pressure. Valuation multiples appear deceptively attractive due to low P/E and P/S ratios, but these are distorted by weak or negative margins and declining earnings. The technical trend is bearish, insider activity shows net selling, and long-term price performance remains deeply negative, reinforcing a high-risk profile.

The company presents a stark contrast between deep value metrics and deteriorating fundamental growth. While the Piotroski F-Score of 5/9 indicates a stable financial baseline, the business is struggling with a -16.50% YoY revenue decline and a -71.4% crash in YoY EPS growth. Valuation is highly attractive on a Price-to-Book (0.71) and Price-to-Sales (0.29) basis, but the negative ROE and poor Quick Ratio (0.30) suggest significant liquidity risks and operational inefficiency. The 'Strong Buy' analyst consensus conflicts with a bearish technical trend (10/100), suggesting a speculative value play rather than a growth investment.